Pam Belluck
Posts
Legal Actions Seek Guarantee of Abortion Access for Patients in Medical Emergencies
New cases say fear and confusion about abortion bans in three states are causing doctors and hospitals to deny medically necessary abortions.
FDA Approves First Pill for Postpartum Depression
Because the pill works faster than other antidepressants and is taken for only two weeks, it may encourage more treatment of the debilitating condition.
Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds
A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages...
F.D.A. Approves First U.S. Over-the-Counter Birth Control Pill
The price of the pill, which has not been announced, will determine how affordable it will be when it becomes available in early 2024.
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly...
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high...
Wyoming Judge Temporarily Blocks State’s Ban on Abortion Pills
The law was to take effect on July 1. It is the only state law that specifically outlaws the most common abortion method in the...
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.